Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Rev. esp. patol. torac ; 23(4): 291-296, oct.-dic. 2011. tab
Article in Spanish | IBECS | ID: ibc-104705

ABSTRACT

Objetivos: Estudiar si el syndrome de apneas-hipopneas del sueño (SAHS) induce estrés miocárdio valorado mediante marcadores séricos. Pacientes y métodos: Estudio (..) (AU)


Patients and methods: Prospective, observational study with consecutive sampling conducted in patients with (..)(AU)


Subject(s)
Humans , Sleep Apnea, Obstructive/physiopathology , Myocardial Ischemia/physiopathology , Oxygen Consumption/physiology , Myocardial Stunning/physiopathology , Biomarkers/analysis , Polysomnography
2.
Transplant Proc ; 42(8): 3020-2, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20970598

ABSTRACT

UNLABELLED: INTRODUCTIóN: After cystic fibrosis, lung transplantation (LT) patients with prior chronic obstructive pulmonary disease (COPD) are most susceptible to loss of bone mineral density (BMD). OBJECTIVES: To determine the prevalence of BMD loss among COPD patients being evaluated as LT candidates, seeking to identify, their risk profile. PATIENTS AND METHODS: This cross-sectional study included COPD patients who were LT candidates evaluated from January 2007 to December 2009. To identify patients at risk of fracture, BMD at the femoral neck and lumbar spine was assessed by bone densitometry. For categorization, we followed the World Health Organization criteria. To evaluate the risk profile, we recorded data on age, sex, smoking, lung function forced expiratory volume in 1 second, distance covered in the 6-minute walk test, body mass index, and degree of dyspnea. We recorded individual data as well as grouped them the multidimensional BODE (Body mass index Obstruction Dyspnea Exercise capacity) index. RESULTS: The study cohort consisted of 64 patients (51 men and 13 women). The overall prevalence of low BMD in any of the explored territories was 84.4%, affecting 88.2% of men and 69.2% of women. Osteoporosis was identified in 56.2% of patients, reaching a serious degree in 11/64 (17.2%). No significant differences were observed in any evaluated parameter when patients were separated into those with normal versus pathological BMD. When patients with osteopenia and osteoporosis were compared, we observed that the former showed a lower exercise capacity (P=.023) and a higher BODE index (P=.002). CONCLUSIONS: The prevalence of a low BMD level was increased among male patients with a worse BODE index, especially due to a reduced exercise capacity.


Subject(s)
Bone Density , Lung Neoplasms , Pulmonary Disease, Chronic Obstructive/physiopathology , Cohort Studies , Cross-Sectional Studies , Female , Humans , Male , Prevalence , Pulmonary Disease, Chronic Obstructive/surgery
3.
Transplant Proc ; 42(8): 3208-10, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20970654

ABSTRACT

INTRODUCTION: The loss of bone mineral density (BMD) affects more than half of the patients on the waiting list for lung transplantation (LT), increasing their disease burden. OBJECTIVE: To describe the prevalence of BMD loss among patients evaluated as candidates for LT. PATIENTS AND METHODS: We included all hospitalized patients evaluated as LT candidates over the last 3 years, excluding pediatric subjects under 17 years of age. We estimated BMD in the femoral neck and lumbar spine. Categorization used the World Health Organization criteria. RESULTS: Among 156 patients, 64 (41%) had chronic obstructive pulmonary disease (COPD) with only 2 (3.1%) having densitometry before referral; 55 (35.3%), interstitial lung disease (ILD) with 9 (16.4%) BMD values; and 21 (13.5%) cystic fibrosis (CF) with only 3 (14.3%) with BMD screening. The 116 patients (74.4%) who had BMD below normal values included 84.4% of COPD, 67.3% of the ILD, and 81% of the CF patients. The detection of these patients allowed us to initiate preventive treatment depending on the degree of risk of bone fracture. Half of the patients evaluated were eventually included on the LT waiting list, with 70% of them finally receiving a transplant. CONCLUSIONS: Bone mineral loss was highly prevalent among this population but its investigation before referral for LT was scarce. Its identification allows primary or secondary prophylaxis to be started, seeking to reduce the risk of bone fracture after transplantation.


Subject(s)
Bone Density , Lung Transplantation , Female , Humans , Male
4.
Rev. esp. patol. torac ; 22(3): 185-190, jul.-sept. 2010. ilus, tab
Article in Spanish | IBECS | ID: ibc-97259

ABSTRACT

Introducción: en el síndrome de apneas-hipopneas del sueño (SAHS) la lesión del endotelio vascular es uno de los mecanismos involucrados en la aterogénesis (..) (AU)


Introduction: In Sleep Apnoea-Hypopnea Syndrome (SAHS) an injury to the vascular endothelium is one of the mechanism (..) (AU)


Subject(s)
Humans , Sleep Apnea, Obstructive/physiopathology , Hypoxia/physiopathology , Cell Adhesion Molecules , Oxygen Consumption/physiology , Age and Sex Distribution , Cardiovascular Diseases/epidemiology , Risk Factors , Prospective Studies , Polysomnography
5.
Rev. esp. patol. torac ; 21(3): 154-158, jul.-sept. 2009. ilus, tab
Article in Spanish | IBECS | ID: ibc-80757

ABSTRACT

Introducción: en el síndrome de apneas-hipopneas del sueño (SAHS) son frecuentes los episodios de hipoxemia-reoxigenación que pueden producir sustancias oxígeno reactivas y estrés oxidativo. Pacientes y método: estudio prospectivo, con muestreo consecutivo, para determinar si la hipoxemia nocturna puede provocar oxidación proteica. Fueron incluidos pacientes con sospecha de SAHS, indicación de una polisomnografía, edad comprendida entre 25 y 49 años, y ausencia de enfermedad sistémica. Se compararon los resultados observados en un grupo clínico (IAH > 10) con los de un grupo control (IAH < 5). Resultados: se excluyeron 3 pacientes por presentar un IAH entre 5 y 10. Fueron incluidos 36 sujetos (edad = 40 ± 6,1 años, 30 hombres y 6 mujeres, IMC = 31 ± 5,9), 23 pertenecientesínas carboniladas fueron de al grupo clínico y 13 al grupo control. En el grupo clínico, los valores de prote 0,14 ± 0,179 nmol/mg y de 0,10 ±0,066 nmol/mg en el grupo control (p = 0,348). No se observó correlación significativa entre las cifras de proteínas carboniladas y el índice de apneas-hipopneas (rho = 0,197; p = 0,249), índice de de saturación >3% (rho = 0,129, p = 0,452) y porcentaje de sueño con SaO2 <90% (rho = 0,058, p = 0,736). Conclusiones: en pacientes con edad media y SAHS moderado, las proteínas carboniladas séricas se observaron más elevadas, aunque sin alcanzar diferencias significativas (AU)


Introduction: episodes of hypoxemia-reoxigenation are frequent insleep apnea-hypopnea syndrome (SAHS) and can produce reactiveoxygen substances and oxidative stress.Patients and methods: prospective study, with consecutive sampling to determine if nocturnal hypoxemia can produce oxidation. Patients with SAHS suspicion, polysomnography indication, age between 25-49 years old and without systemic disease were included. Results obtained in clinical group (IAH > 10) were comparedwith control group (IAH < 5). Resul years old, 30 men and 6 women, BMI = 31 ± 5.9), 23 patients were from clinical group and 13 from control group. In clinical group, carbonylated proteins values were 0.14 ± 0.179 nmol/mg and 0.10 ± 0.066 nmol/mg incontrol group (p = 0.348). There was not significative correlation between carbonyl proteins and apnea-hypopnea index (rho = 0.197, p = 0.249), desaturation index >3% (rho = 0.129, p = 0.452) and sleep time spent with SaO2 <90% (rho = 0.058, p = 0.736). Conclusions: in patientes with mean age and moderate SAHS, protein carbonyls were higher althout not reaching significant differences (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Sleep Apnea Syndromes/metabolism , Oxidation-Reduction , Proteins/metabolism , Severity of Illness Index , Case-Control Studies , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...